Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.
NCT ID: NCT04444726
Last Updated: 2021-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-01-20
2020-11-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis
NCT01402414
Phototherapy Combination With Topicals in Vitiligo
NCT04440371
Topical PDT Cream Without Irradiation Source in the Acne Treatment
NCT02313467
Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis
NCT05875285
Treatment of Axillary Hyperhidrosis With Long-pulsed Nd:YAG Laser or IPL
NCT04227691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phototherapy "PUVA" +traditional medical treatmentn
patient sock his hands in a bath containing water with the constitution of psoralen "meladinine " capsule for 20 minutes then irradiated at the UVA device for 3 sessions per week for 8 weeks Plus the traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.
Ultra Violet A Device.+ Topical medical treatment
Hands of the patient are irradiated in the UVA device after soaking for 20 minutes into 10 litres of water containing psoralen "meladenine capsule".
Topical medical treatment (Betamethasone dipropionate 0.05% " diprolene " )
thin film of the cream is being applied to the affected areas for 2 times per day.
Tap Water Iontophoresis + Traditional medical treatment
Tap-water iontophoresis was given 3 times weekly for 10 min The direct current level was slowly increased, guided by the occurrence of tingling sensations. The maximum level was 30mA. Plus the traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.
Iontophoresis device + Topical medical treatment
Tap-water iontophoresis was given 3 times weekly for 10 min. The direct current level was slowly increased, guided by the occurrence of tingling sensations. The maximum level was 30 mA.
Topical medical treatment (Betamethasone dipropionate 0.05% " diprolene " )
thin film of the cream is being applied to the affected areas for 2 times per day.
traditional medical treatment
Traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.
Topical medical treatment (Betamethasone dipropionate 0.05% " diprolene " )
thin film of the cream is being applied to the affected areas for 2 times per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultra Violet A Device.+ Topical medical treatment
Hands of the patient are irradiated in the UVA device after soaking for 20 minutes into 10 litres of water containing psoralen "meladenine capsule".
Iontophoresis device + Topical medical treatment
Tap-water iontophoresis was given 3 times weekly for 10 min. The direct current level was slowly increased, guided by the occurrence of tingling sensations. The maximum level was 30 mA.
Topical medical treatment (Betamethasone dipropionate 0.05% " diprolene " )
thin film of the cream is being applied to the affected areas for 2 times per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from AD of dyshidrotic as well as dry types of more than 6-months duration
* Traditional types of treatment options, including oral or topical corticosteroids, proved ineffective.
Exclusion Criteria
* Skin malignancy at the area to be treated.
* Acute infection at the treated area.
* Children received radiotherapy in the area to be treated during the last 6 months.
* Children received corticosteroid therapy topically within 14 days before treatment, or systemic corticosteroids or any immunosuppressive drugs within the last 4 weeks.
* Circulatory and sensory disorders and children with diabetes mellitus.
9 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olfat Ibrahim Ali
Assistant Professor , department of physical therapy for basic science, Faculty of Physical Therapy , Cairo university.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banha University
Banhā, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2776
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.